Likai Lin
Biographic Data
| ID | 10000823 |
|---|---|
| NAME | Likai Lin |
| GIVEN NAMES | Likai |
| FAMILY NAME | Lin |
| SIGNATURE | LIN L |
| AFFILIATIONS | Wuhan University |
| ORCID | 0009-0002-4631-5692 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Cost-of-illness analysis and management insights of DRG payment and clinical pathway implementation for radical prostatectomy patients
The challenges of medical insurance cost control and quality management for major or complex diseases are becoming increasingly prominent. This study analyzed the hospitalization costs of patients undergoing radical prostatectomy (RP) to explore the impact and effectiveness of diagnosis-related group (DRG) payment and clinical pathway (CP) management, providing insights for refined cost control. A total of 179 patients discharged after radical pr…
Effects of DRG/DIP payment reform on hospital pharmacy administration and pharmaceutical services in China
Background In China, a government-led policy introduced in 2019 and 2020 aims to reduce medical costs through a national medical care payment system based on Diagnostic-Related Groups (DRG) and Diagnosis-Intervention Packet (DIP). Hospital pharmacists play a crucial role in the implementation of this policy by enhancing the rational use of medicines and delivering pharmaceutical services. The purpose of this study is to assess the current state o…
Current scenario and challenges of clinical pharmacists to implement pharmaceutical care in DRG/DIP payment hospitals in China
Purpose: The Diagnosis-Related Group (DRG) or Diagnosis-Intervention Packet (DIP) payment system, now introduced in China, intends to streamline healthcare billing practices. However, its implications for clinical pharmacists, pivotal stakeholders in the healthcare system, remain inadequately explored. This study sought to assess the perceptions, challenges, and roles of clinical pharmacists in China following the introduction of the DRG or DIP p…
Development and validation of the regarding infection prevention and control among environmental service workers on knowledge, attitudes, practise, and experience questionnaire
Purpose This study aimed to develop and test the validity and reliability of the Knowledge, Attitudes, Practise, and Experience regarding Infection Prevention and Control-associated Questionnaire for environmental service workers. Design This study was a development and validation study of a questionnaire using multiple methods, including literature review, questionnaire survey, and Delphi technique. Methods Phase I of the study entailed the deve…
No prominent works on this page.
Development and validation of the regarding infection prevention and control among environmental service workers on knowledge, attitudes, practise, and experience questionnaire
Purpose This study aimed to develop and test the validity and reliability of the Knowledge, Attitudes, Practise, and Experience regarding Infection Prevention and Control-associated Questionnaire for environmental service workers. Design This study was a development and validation study of a questionnaire using multiple methods, including literature review, questionnaire survey, and Delphi technique. Methods Phase I of the study entailed the deve…
Current scenario and challenges of clinical pharmacists to implement pharmaceutical care in DRG/DIP payment hospitals in China
Purpose: The Diagnosis-Related Group (DRG) or Diagnosis-Intervention Packet (DIP) payment system, now introduced in China, intends to streamline healthcare billing practices. However, its implications for clinical pharmacists, pivotal stakeholders in the healthcare system, remain inadequately explored. This study sought to assess the perceptions, challenges, and roles of clinical pharmacists in China following the introduction of the DRG or DIP p…
Effects of DRG/DIP payment reform on hospital pharmacy administration and pharmaceutical services in China
Background In China, a government-led policy introduced in 2019 and 2020 aims to reduce medical costs through a national medical care payment system based on Diagnostic-Related Groups (DRG) and Diagnosis-Intervention Packet (DIP). Hospital pharmacists play a crucial role in the implementation of this policy by enhancing the rational use of medicines and delivering pharmaceutical services. The purpose of this study is to assess the current state o…
Cost-of-illness analysis and management insights of DRG payment and clinical pathway implementation for radical prostatectomy patients
The challenges of medical insurance cost control and quality management for major or complex diseases are becoming increasingly prominent. This study analyzed the hospitalization costs of patients undergoing radical prostatectomy (RP) to explore the impact and effectiveness of diagnosis-related group (DRG) payment and clinical pathway (CP) management, providing insights for refined cost control. A total of 179 patients discharged after radical pr…
Business (3 works) · Medicine (3 works) · Payment (3 works) · Clinical pharmacy (2 works) · Healthcare Systems and Reforms (2 works) · Pharmaceutical Practices and Patient Outcomes (2 works) · Pharmacy (2 works) · Clinical pathway (1 work) · Clinical practice guidelines implementation (1 work) · Computer Science (1 work)